Belfast experience with P6 acupuncture antiemesis.

Area of Science:

• Integrative Medicine
• Clinical Pharmacology
• Acupuncture Research

Background:

• Postoperative nausea and vomiting (PONV) are common complications.
• Minimizing variables in clinical settings is crucial for evaluating interventions.
• Standard antiemetics have limitations and side effects.

Purpose of the Study:

• To evaluate the prophylactic antiemetic efficacy of P6 (Neiguan) acupuncture.
• To compare invasive (needling) versus non-invasive (transcutaneous electrical, acupressure) P6 stimulation.
• To assess the role of P6 acupuncture as an adjunct therapy for chemotherapy-induced nausea and vomiting.

Main Methods:

• Controlled clinical trials with reduced variables.
• Invasive P6 acupuncture (manual and electrical needling).
• Non-invasive P6 stimulation (transcutaneous electrical stimulation, acupressure).
• Sham acupuncture point stimulation and post-emetic stimulus administration.
• Blockade of P6 effect with local anesthesia.

Main Results:

• P6 acupuncture demonstrated effective prophylactic antiemetic action in a controlled setting.
• Invasive and non-invasive P6 stimulation were effective, with invasive methods providing sustained effects.
• Non-invasive methods were comparable to standard antiemetics in the early postoperative period.
• Stimulation of a sham point or post-emetic stimulus administration was ineffective.
• Local anesthesia at P6 blocked the antiemetic effect.
• P6 acupressure showed moderate efficacy for morning sickness, potentially with a psychological component.
• P6 acupuncture combined with standard antiemetics aided in reducing chemotherapy-induced nausea and vomiting, with acupressure prolonging effects for 24 hours.

Conclusions:

• P6 (Neiguan) acupuncture is a proven prophylactic antiemetic for postoperative sickness.
• Both invasive and non-invasive P6 stimulation offer therapeutic benefits, with varying durations of action.
• P6 acupuncture serves as a valuable adjuvant therapy, particularly in managing chemotherapy-induced nausea and vomiting.